Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (321-330 of 516) with videos related to

Pageof 52
Sort By:
Blood Cancer Journal|April 2, 2022
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patientsSamilia Obeng-Gyasi, Noah Graham, Shaji Kumar, et al.
American Journal of Hematology|October 8, 2008
A novel report of cig-FISH and cytogenetics in POEMS syndromeAlan H Bryce, Rhett P Ketterling, Morie A Gertz, et al.
British Journal of Haematology|June 24, 2009
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myelomaChristine Chen, Donna E Reece, David Siegel, et al.
Leukemia|April 15, 2018
Treatment approaches and outcomes in plasmacytomas: analysis using a national datasetGaurav Goyal, Adam C Bartley, Shealeigh Funni, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 13, 2025
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survivalMatthew J Rees, Nadia Toumeh, Angela Dispenzieri, et al.
Leukemia|April 13, 2022
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Leukemia|January 29, 2022
Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and ConceptsThomas A D'Amico, Lindsey A M Bandini, Alan Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurementsShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Pageof 52

Showing results (321-330 of 516) with videos related to

Sort By:
Pageof 52
Blood Cancer Journal|April 2, 2022
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patientsSamilia Obeng-Gyasi, Noah Graham, Shaji Kumar, et al.
American Journal of Hematology|October 8, 2008
A novel report of cig-FISH and cytogenetics in POEMS syndromeAlan H Bryce, Rhett P Ketterling, Morie A Gertz, et al.
British Journal of Haematology|June 24, 2009
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myelomaChristine Chen, Donna E Reece, David Siegel, et al.
Leukemia|April 15, 2018
Treatment approaches and outcomes in plasmacytomas: analysis using a national datasetGaurav Goyal, Adam C Bartley, Shealeigh Funni, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 13, 2025
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survivalMatthew J Rees, Nadia Toumeh, Angela Dispenzieri, et al.
Leukemia|April 13, 2022
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Leukemia|January 29, 2022
Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and ConceptsThomas A D'Amico, Lindsey A M Bandini, Alan Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurementsShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Pageof 52